Market closedNon-fractional
Mainz Biomed/MYNZ
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Mainz Biomed
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.
Ticker
MYNZ
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
Mainz, Germany
Employees
68
Website
mainzbiomed.com
Mainz Biomed Metrics
BasicAdvanced
$8.5M
Market cap
-
P/E ratio
-$1.62
EPS
0.30
Beta
-
Dividend rate
Price and volume
Market cap
$8.5M
Beta
0.3
Financial strength
Current ratio
0.972
Quick ratio
0.804
Long term debt to equity
67.582
Total debt to equity
228.386
Interest coverage (TTM)
-47.62%
Management effectiveness
Return on assets (TTM)
-93.42%
Return on equity (TTM)
-303.20%
Valuation
Price to revenue (TTM)
7.038
Price to book
2.51
Price to tangible book (TTM)
-56.19
Price to free cash flow (TTM)
-0.264
Growth
Revenue change (TTM)
69.00%
Earnings per share change (TTM)
-13.14%
3-year revenue growth
21.97%
3-year earnings per share growth
149.16%
What the Analysts think about Mainz Biomed
Analyst Ratings
Majority rating from 3 analysts.
Mainz Biomed Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$200K
100.00%
Net income
-$5.1M
-17.74%
Profit margin
-2,550.00%
-58.87%
Mainz Biomed Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.56
-$0.39
-$0.24
-
Expected
-$0.42
-$0.47
-$0.32
-$0.25
Surprise
33.33%
-17.61%
-24.21%
-
Mainz Biomed News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Mainz Biomed stock?
Mainz Biomed (MYNZ) has a market cap of $8.5M as of July 06, 2024.
What is the P/E ratio for Mainz Biomed stock?
The price to earnings (P/E) ratio for Mainz Biomed (MYNZ) stock is 0 as of July 06, 2024.
Does Mainz Biomed stock pay dividends?
No, Mainz Biomed (MYNZ) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Mainz Biomed dividend payment date?
Mainz Biomed (MYNZ) stock does not pay dividends to its shareholders.
What is the beta indicator for Mainz Biomed?
Mainz Biomed (MYNZ) has a beta rating of 0.3. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Mainz Biomed stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.